SARA HOGG: Open Payments
NPI 1225391139 · LEXINGTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 42 payments from 20 companies in 2025. Trend: 2023 $624 · 2024 $751 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $116 |
| Novo Nordisk Inc | 5 | $100 |
| Stryker Corporation | 2 | $84 |
| Dexcom, Inc. | 2 | $84 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| PFIZER INC. | 3 | $58 |
| Abbott Laboratories | 4 | $58 |
| Lilly USA, LLC | 2 | $48 |
| Astellas Pharma US Inc | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
Products named: VRAYLAR, Wegovy, Dexcom G6 Transmitter, Veozah, FLOWTRIEVER CATHETER, S, CLOTTRIEVER BOLD CATHETER, AIRSUPRA, LEQVIO.
Industry payments across SC — which companies pay providers there.
